中国神经再生研究:英文版2023,Vol.18Issue(3):P.643-651,9.
TMEM16F may be a new therapeutic target for Alzheimer’’s disease
Zhi-Qiang Cui 1Xiao-Ying Hu 1Tuo Yang 1Jing-Wei Guan 1Ying Gu 1Hui-Yuan Li 1Hui-Yu Zhang 1Qing-Huan Xiao 2Xiao-Hong Sun1
作者信息
- 1. Department of Neurology,The Fourth Affiliated Hospital of China Medical University,Shenyang,Liaoning Province,China
- 2. Department of Ion Channel Pharmacology,School of Pharmacy,China Medical University,Shenyang,Liaoning Province,China
- 折叠
摘要
关键词
Alzheimer’s disease/Aβplaque/inflammatory cytokines/M1 phenotype/M2 phenotype/microglia polarization/neuroinflammation/NLRP3 inflammasome/siRNA/TMEM16F分类
医药卫生引用本文复制引用
Zhi-Qiang Cui,Xiao-Ying Hu,Tuo Yang,Jing-Wei Guan,Ying Gu,Hui-Yuan Li,Hui-Yu Zhang,Qing-Huan Xiao,Xiao-Hong Sun..TMEM16F may be a new therapeutic target for Alzheimer’’s disease[J].中国神经再生研究:英文版,2023,18(3):P.643-651,9.